Indian government approves emergency use of 2 Covid vaccines

Last updated on December 30th, 2021 at 05:57 am

Amid the surging Covid-19 cases, the Indian government has approved two vaccines and one antiviral drug for emergency usage so that they can strengthen the fight against the pandemic.

The Union health minister Mansukh Mandaviya said on Tuesday that it has authorized approval of two vaccines and one antiviral drug to promote vaccination during the pandemic time.

Mansukh Mandaviya made an official statement on Twitter stressing, “Further strengthening the fight against Covid-19, CDSCO, health ministry has given 3 approvals in a single day for CORBEVAX vaccine, COVOVAX vaccine, antiviral drug Molnupiravir.”

Related Posts

• Covid-19 threat in India: Covaxin only vaccine for children of 15-18 years; booster shots after second jab
• Emergency Use Antiviral Drug Gets Pharma Consortium Support
• Expo 2020 Gets Open Invitation To Invest In India
• Health Ministry Pushes States UT For Third Wave Prepardness
• India rolls out vaccination for children: first day registers 41 lakh vaccinated
• Lancet Study: Covishield vaccine remained efficient during Delta surge
• New Variant Sends Shockwaves Into Airline Hotel Stocks
• Omicron Surge Leads To Night Curfew In Seven India States
• Omicron threat: Genomic Sequencing Consortium recommends booster shots for people over 40 years
• Prime Minister Narendra Modi announces booster shots for frontline workers, 60-plus population; vaccination for 15-18 age group

He also added that the usage is strictly meant for emergency usage. The vaccines have approved the two vaccines only after the Subject Expert Committee (SEC) set up for the pandemic of the Central Drugs Standard Control Organisation (CDSCO) granted the permission of the vaccine.

COVOVAX will be produced by the Serum Institute of India (SII)  while the second vaccine, Corbevax, will be made by Biological-E.

The health minister today said that the latter will be the country’s first indigenously developed RBD protein sub-unit in its fight against the virus. India has till now approved eight vaccines for emergency use. This includes Covishield, Covaxin, Sputnik V, Moderna, Johnson and Johnson and ZyCoV-D .